EPISODE · Jan 21, 2026 · 1H 1M
Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review
from Hematologic Oncology Update
Prof Michael Dickinson from Peter MacCallum Cancer Centre in Melbourne, Australia, and Dr Laurie H Sehn from the University of British Columbia in Vancouver, Canada, discuss clinical cases and recent findings from the 2025 ASH Annual Meeting relating to the use of bispecific antibodies in the management of lymphoma.CME information and select publications here.
Embed this episode
NOW PLAYING
Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review
0:00
1:01:12
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Hematologic Oncology Update?
This episode is 1 hour and 1 minute long.
When was this Hematologic Oncology Update episode published?
This episode was published on January 21, 2026.
Can I download this Hematologic Oncology Update episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!